Navigation Links
Yayi International Appoints New Chief Financial Officer
Date:2/26/2010

TIANJIN, China, Feb. 26 /PRNewswire-Asia-FirstCall/ -- Yayi International Inc., (OTC Bulletin Board: YYIN) ("Yayi International" or the "Company"), the first mover and a leading producer and distributor of premium goat milk formula products for infants, toddlers, young children, and adults in the People's Republic of China ("China") today announced the appointment of Ms. Veronica Jing Chen as its new Chief Financial Officer, effective February 24, 2010. Ms. Chen replaces Ms. Tong Li, who resigned for personal reasons on the same day.

Ms. Chen is a seasoned executive with more than 20 years of experience in accounting, financial management, and general management of several public companies. Prior to joining Yayi International, she held Chief Financial Officer positions at several NASDAQ listed Chinese companies, including China Natural Gas, Inc. ( CHNG), China Valves Technology, Inc. and Origin Agritech, Limited. Before that, she served as Senior Director of Finance at iKang Healthcare, Director of Finance at eLong, and Finance Manager of the North China Region for Eli Lilly Asia's China Representative Office.

During her extensive career as a financial executive, Ms. Chen has successfully built and managed accounting systems, improved financial reporting and controls, and implemented internal policies and procedures in compliance with standards required by the Sarbanes-Oxley Act. Ms. Chen currently holds memberships with CPA Australia and The National Institute of Accountants (NIA) of Australia. She received a degree of Doctor of Business Administration from Victoria University, Neuchatel, Switzerland and an MBA degree from the City University of Seattle, Washington, U.S.

"We are pleased to have Ms. Chen joining our senior management team. She joins Yayi International at an exciting time as we are making important strategic moves in production, marketing and distribution," said Ms. Li Liu, Chief Executive Officer of Yayi International. "We believe her breadth and depth of experience with U.S.-listed Chinese companies will strengthen our financial reporting, planning and forecasting capabilities to ensure that we are compliant with regulatory and corporate governance requirements."

"I would also like to thank Ms. Li for her great contribution as Chief Financial Officer since May 2008 while the Company has been undergoing a number of changes. We wish her the best in the future," Ms. Liu concluded.

About Yayi International

Yayi International is the first mover and a leading producer and distributor of premium goat milk formula products for infants, toddlers, young children and adults in China. Its current formula product lines are targeted at the premium market segment and health-conscious consumers. The Company's distribution network comprises of approximately 3,600 retail points including infant-maternity store chains, supermarkets, and drug stores as well as catalogue sales across China.

Forward-looking Statements:

This press release contains certain statements that may include 'forward-looking statements'. All statements other than statements of historical fact included herein are 'forward-looking statements'. These forward looking statements are often identified by the use of forward-looking terminology such as 'believes,' 'expects' or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website ( http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Company Contact:
     Ms. Veronica Chen
     Chief Financial Officer
     Email: vjchen36@hotmail.com
     Tel:   +86-22-5869-1668

    Investor Relations Contact:
     Ms. Linda Salo
     Email: linda.salo@ccgir.com
     Tel:   +1-646-922-0894 (NY office)

     Mr. Crocker Coulson,
     President
     Email: crocker.coulson@ccgir.com
     Tel:   +1-646-213-1915 (NY office)
     Web:   http://www.ccgirasia.com

SOURCE Yayi International Inc.

Back to top
'/>"/>
SOURCE Yayi International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Thomas E. Mower Meets With Dalai Lama; Receives Prestigious Champion Award from Whole Child International
2. Tahitian Noni International Leaves the Superfruits Behind
3. Clinton Bush Haiti Fund Awards International Medical Corps $500,000 for Emergency Medical Care and Long-Term Rebuilding
4. Vetted International Launches Medical Management Program to Service Kuwait
5. Confronting infectious disease threats at large-scale international events
6. Live access to breaking news from the American Stroke Association’s International Stroke Conference 2010
7. National Launch of Jusuru International
8. International Medical Corps and Agility Partner in Delivering Quake Relief to Haiti
9. BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research
10. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
11. Tyco International to Host 2010 Annual General Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... announces today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® ... Western Pennsylvania. , The program, developed in association with efforts by the American ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... Santa Monica, CA (PRWEB) , ... March 28, ... ... expert, Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer ... newest gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017 ... to reach USD 16.0 billion by 2025, according to ... growing prevalence of chronic diseases is anticipated to be ... analyzers, which thereby widens the scope for growth during ... and bariatric population, which is highly susceptible to chronic ...
(Date:3/27/2017)... BOSTON , March 27, 2017  Allergan ... and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ... innovative therapies based upon tetracycline chemistry, announced that ... the treatment of moderate to severe acne met ... a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with ...
Breaking Medicine Technology: